European Proteomics Amyloid Network
Bringing together scientists and clinicians since 2017
The European Proteomics Amyloid Network (EPAN) is an international Europe-centered collaboration network established in 2017, bringing together scientists and clinicians with a shared interest in the development and application of proteomics for amyloid diagnosis and research.
EPAN provides a forum for open scientific exchange, discussion of best practices, and inter-laboratory collaboration in amyloid typing and related research. Previous meetings have been held in London (2017), Uppsala (2019), Kiel (2023) and Pavia (2025), with additional online meetings and working-group specific activities.
As mass spectrometry technologies become more widely accessible, the network has expanded and 17 countries are now represented.
